221 related articles for article (PubMed ID: 31378676)
1. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D): Patient Summary.
American Gastroenterological Association
Gastroenterology; 2019 Sep; 157(3):856-857. PubMed ID: 31378676
[No Abstract] [Full Text] [Related]
2. AGA Clinical Practice Guidelines on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):851-854. PubMed ID: 31302098
[No Abstract] [Full Text] [Related]
3. Spotlight: Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Smalley W; Falck-Ytter C; Carrasco-Labra A; Wani S; Lytvyn L; Falck-Ytter Y
Gastroenterology; 2019 Sep; 157(3):858. PubMed ID: 31377275
[No Abstract] [Full Text] [Related]
4. Irritable Bowel Syndrome in Adults (IBS-D): Clinical Decision Support Tool.
American Gastroenterological Association
Gastroenterology; 2019 Sep; 157(3):855. PubMed ID: 31323183
[No Abstract] [Full Text] [Related]
5. AGA Technical Review on the Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
Carrasco-Labra A; Lytvyn L; Falck-Ytter Y; Surawicz CM; Chey WD
Gastroenterology; 2019 Sep; 157(3):859-880. PubMed ID: 31351880
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
Schiller LR
Am J Gastroenterol; 2018 May; 113(5):660-669. PubMed ID: 29713027
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes.
Lin S; Mooney PD; Kurien M; Aziz I; Leeds JS; Sanders DS
Eur J Gastroenterol Hepatol; 2014 Oct; 26(10):1176-80. PubMed ID: 25076066
[TBL] [Abstract][Full Text] [Related]
8. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
9. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
10. Factorial study of moxibustion in treatment of diarrhea-predominant irritable bowel syndrome.
Zhao JM; Wu LY; Liu HR; Hu HY; Wang JY; Huang RJ; Shi Y; Tao SP; Gao Q; Zhou CL; Qi L; Ma XP; Wu HG
World J Gastroenterol; 2014 Oct; 20(37):13563-72. PubMed ID: 25309087
[TBL] [Abstract][Full Text] [Related]
11. [Diarrhea predominant irritable bowel syndrome].
Sabaté JM; Coffin B
Rev Prat; 2008 Jun; 58(11):1194-8. PubMed ID: 18689115
[TBL] [Abstract][Full Text] [Related]
12. [Functional diarrhea - pathophysiology, investigation and treatment].
Schaub N; Degen L
Ther Umsch; 2014 Sep; 71(9):551-8. PubMed ID: 25154691
[TBL] [Abstract][Full Text] [Related]
13. Irritable bowel syndrome: what do the new Rome IV diagnostic guidelines mean for patient management?
Whitehead WE; Palsson OS; Simrén M
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):281-283. PubMed ID: 28276814
[No Abstract] [Full Text] [Related]
14. ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
Lacy BE; Pimentel M; Brenner DM; Chey WD; Keefer LA; Long MD; Moshiree B
Am J Gastroenterol; 2021 Jan; 116(1):17-44. PubMed ID: 33315591
[TBL] [Abstract][Full Text] [Related]
15. [Alternative medicine treatment of irritable bowel syndrome -- what are the guidelines?].
Hakimi R
Versicherungsmedizin; 2015 Mar; 67(1):32-3. PubMed ID: 25971148
[No Abstract] [Full Text] [Related]
16. Evidence-based management of irritable bowel syndrome with diarrhea.
Pimentel M
Am J Manag Care; 2018 Jan; 24(3 Suppl):S35-S46. PubMed ID: 29372991
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
18. Update on chronic diarrhea: a run-through for the clinician.
Sandhu DK; Surawicz C
Curr Gastroenterol Rep; 2012 Oct; 14(5):421-7. PubMed ID: 22903799
[TBL] [Abstract][Full Text] [Related]
19. Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility.
Savarino E; Zingone F; Barberio B; Marasco G; Akyuz F; Akpinar H; Barboi O; Bodini G; Bor S; Chiarioni G; Cristian G; Corsetti M; Di Sabatino A; Dimitriu AM; Drug V; Dumitrascu DL; Ford AC; Hauser G; Nakov R; Patel N; Pohl D; Sfarti C; Serra J; Simrén M; Suciu A; Tack J; Toruner M; Walters J; Cremon C; Barbara G
United European Gastroenterol J; 2022 Jul; 10(6):556-584. PubMed ID: 35695704
[TBL] [Abstract][Full Text] [Related]
20. British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.
Vasant DH; Paine PA; Black CJ; Houghton LA; Everitt HA; Corsetti M; Agrawal A; Aziz I; Farmer AD; Eugenicos MP; Moss-Morris R; Yiannakou Y; Ford AC
Gut; 2021 Jul; 70(7):1214-1240. PubMed ID: 33903147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
